| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 953-961, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
KS Kilgore, CM Flory, BF Miller, VM Evans and JS Warren
Department of Pathology, University of Michigan Medical School, Ann Arbor, USA.
Cell surface assembly of the membrane attack complex (MAC) of complement occurs in a variety of pathophysiological settings. Depending upon the density and size distribution of pores formed by the MAC and the functional integrity of membrane regulators of complement activation, the MAC can either cause direct cell lysis or transduce cell activation. We have examined the functional capacity of sublytic concentrations of MAC to induce the secretion of specific alpha- and beta-chemokines from human umbilical vein endothelial cells (HUVECs). Endothelial cell activation by the MAC has particular relevance to complement-dependent inflammatory processes including ischemia- reperfusion injury and acute lung injury. Assembly of sublytic concentrations of the MAC on HUVECs resulted in the sequential secretion of both neutrophil and monocyte chemotactic activities. Analysis of conditioned medium from MAC-bearing HUVECs revealed that the neutrophil chemotactic activity was largely attributable to interleukin (IL)-8, whereas the monocyte chemotactic activity, which was detected later (peak at 8 hours versus 4 hours), was largely attributable to MCP-1. This temporal pattern of MAC-induced secretion of IL-8 and MCP-1 was confirmed using IL-8- and MCP-1-specific enzyme- linked immunosorbent assays. Northern hybridization analysis of HUVECs revealed that MAC deposition was accompanied by an increase in IL-8 and MCP-1 mRNA levels. These data indicate that assembly of sublytic concentrations of the MAC on HUVECs can induce the sequential secretion of both neutrophil and monocyte chemotactic activities and that the former is largely attributable to IL-8 whereas the latter is largely attributable to MCP-1.
This article has been cited by other articles:
 |
|
 |
|
  G. J. Brunn, S. Saadi, and J. L. Platt Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells Circ. Res., April 11, 2008; 102(7): 823 - 830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Hohenstein, A. Braun, K. U. Amann, R. J. Johnson, and C. P. M. Hugo A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1144 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. La Bonte, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1282 - H1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Matthijsen, D. Huugen, N. T. Hoebers, B. de Vries, C. J. Peutz-Kootstra, Y. Aratani, M. R. Daha, J. W. C. Tervaert, W. A. Buurman, and P. Heeringa Myeloperoxidase Is Critically Involved in the Induction of Organ Damage after Renal Ischemia Reperfusion Am. J. Pathol., December 1, 2007; 171(6): 1743 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, J. Arp, W. Liu, S. J. Faas, J. Jiang, D. R. Gies, S. Ramcharran, B. Garcia, R. Zhong, and R. P. Rother Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation J. Immunol., October 1, 2007; 179(7): 4451 - 4463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Pickering, J. Warren, K. L. Rose, F. Carlucci, Y. Wang, M. J. Walport, H. T. Cook, and M. Botto Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice PNAS, June 20, 2006; 103(25): 9649 - 9654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bossi, F. Fischetti, V. Pellis, R. Bulla, E. Ferrero, T. E. Mollnes, D. Regoli, and F. Tedesco Platelet-Activating Factor and Kinin-Dependent Vascular Leakage as a Novel Functional Activity of the Soluble Terminal Complement Complex J. Immunol., December 1, 2004; 173(11): 6921 - 6927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. de Vries, J. Kohl, W. K. G. Leclercq, T. G. A. M. Wolfs, A. A. J. H. M. van Bijnen, P. Heeringa, and W. A. Buurman Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils J. Immunol., April 1, 2003; 170(7): 3883 - 3889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. Laudes, J. C. Chu, M. Huber-Lang, R.-F. Guo, N. C. Riedemann, J. V. Sarma, F. Mahdi, H. S. Murphy, C. Speyer, K. T. Lu, et al. Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells J. Immunol., November 15, 2002; 169(10): 5962 - 5970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. De Bleecker, B. De Paepe, I. E. Vanwalleghem, and J. M. Schroder Differential expression of chemokines in inflammatory myopathies Neurology, June 25, 2002; 58(12): 1779 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. SAADI, L. E. WRENSHALL, and J. L. PLATT Regional manifestations and control of the immune system FASEB J, June 1, 2002; 16(8): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Tran, S. J. Hodgkinson, N. Carter, M. Killingsworth, S. T. Spicer, and B. M. Hall Attenuation of Experimental Allergic Encephalomyelitis in Complement Component 6-Deficient Rats Is Associated with Reduced Complement C9 Deposition, P-Selectin Expression, and Cellular Infiltrate in Spinal Cords J. Immunol., May 1, 2002; 168(9): 4293 - 4300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dobrina, M. Pausa, F. Fischetti, R. Bulla, E. Vecile, E. Ferrero, A. Mantovani, and F. Tedesco Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo Blood, January 1, 2002; 99(1): 185 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. U. Schraufstatter, J. Chung, and M. Burger IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1094 - L1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ozaki, M. Ishizaki, M. Ghazizadeh, and N. Yamanaka Apoptosis mediates decrease in cellularity during the regression of Arthus reaction in cornea Br. J. Ophthalmol., May 1, 2001; 85(5): 613 - 618. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Lekowski, C. D. Collard, W. R. Reenstra, and G. L. Stahl Ulex europaeus agglutinin II (UEA-II) is a novel, potent inhibitor of complement activation Protein Sci., February 1, 2001; 10(2): 277 - 284. [Abstract] [Full Text]
|
|
|
|
|
|
A. Agah, M. C. Montalto, C. L. Kiesecker, M. Morrissey, M. Grover, K. L. Whoolery, R. P. Rother, and G. L. Stahl Isolation, Characterization, and Cloning of Porcine Complement Component C7 J. Immunol., July 15, 2000; 165(2): 1059 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Collard, A. Vakeva, M. A. Morrissey, A. Agah, S. A. Rollins, W. R. Reenstra, J. A. Buras, S. Meri, and G. L. Stahl Complement Activation after Oxidative Stress : Role of the Lectin Complement Pathway Am. J. Pathol., May 1, 2000; 156(5): 1549 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. KALLIO, K. B. LEMSTRÖM, P. J. HÄYRY, U. S. RYAN, and P. K. KOSKINEN Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1332 - 1339. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Dalmasso, B. A. Benson, J. S. Johnson, C. Lancto, and M. S. Abrahamsen Resistance Against the Membrane Attack Complex of Complement Induced in Porcine Endothelial Cells with a Gal{alpha}(1-3)Gal Binding Lectin: Up-Regulation of CD59 Expression J. Immunol., April 1, 2000; 164(7): 3764 - 3773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Collard, A. Agah, W. Reenstra, J. Buras, and G. L. Stahl Endothelial Nuclear Factor-{kappa}B Translocation and Vascular Cell Adhesion Molecule-1 Induction by Complement : Inhibition With Anti-Human C5 Therapy or cGMP Analogues Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Mason, H. Yarwood, K. Sugars, B. P. Morgan, K. A. Davies, and D. O. Haskard Induction of Decay-Accelerating Factor by Cytokines or the Membrane-Attack Complex Protects Vascular Endothelial Cells Against Complement Deposition Blood, September 1, 1999; 94(5): 1673 - 1682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Selvan, H. B. Kapadia, and J. L. Platt Complement-Induced Expression of Chemokine Genes in Endothelium: Regulation by IL-1-Dependent and -Independent Mechanisms J. Immunol., October 15, 1998; 161(8): 4388 - 4395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Boss, X. Wang, L. F. Koppelman, K. Xu, and T. J. Murphy Histamine Induces Nuclear Factor of Activated T Cell-Mediated Transcription and Cyclosporin A-Sensitive Interleukin-8 mRNA Expression in Human Umbilical Vein Endothelial Cells Mol. Pharmacol., August 1, 1998; 54(2): 264 - 272. [Abstract] [Full Text]
|
|
|
|
|
|
M. Torzewski, J. Torzewski, D. E. Bowyer, J. Waltenberger, C. Fitzsimmons, V. Hombach, and H. E. Gabbert Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell {alpha}-Actin in Early Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2448 - 2452. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Tedesco, M. Pausa, E. Nardon, M. Introna, A. Mantovani, and A. Dobrina The Cytolytically Inactive Terminal Complement Complex Activates Endothelial Cells to Express Adhesion Molecules and Tissue Factor Procoagulant Activity J. Exp. Med., May 5, 1997; 185(9): 1619 - 1628. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
